Avacopan

ATC L04AJ05 · 8 markets · 10 records

Avacopan 8 markets · 10 records Forms

AU 3 records · 2 strengths

10 mgcapsuleTAVNEOS+1TAVNEOS avacopan 10 mg hard capsule bottle also in US·GB·CA +2 unknown

Records without a stated strength · 1 TAVNEOS

US 1 records · 1 strengths

10 mgcapsuleTAVNEOS also in AU·GB·CA +2

GB 1 records · 1 strengths

10 mgcapsuleTAVNEOS also in AU·US·CA +2

CA 1 records · 1 strengths

10 mgcapsuleTAVNEOS also in AU·US·GB +2

SG 1 records · 1 strengths

10 mgcapsuleTAVNEOS HARD CAPSULE 10MG also in AU·US·GB +2

CN 1 records · 1 strengths

10 mgcapsule特福尼阿伐可泮 also in AU·US·GB +2

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN
10 mg capsule	TAVNEOS	TAVNEOS	TAVNEOS	TAVNEOS TAVNEOS avacopan 10 mg hard capsule bottle	TAVNEOS HARD CAPSULE 10MG	特福尼阿伐可泮
not disclosed unknown	not recorded	not recorded	not recorded	TAVNEOS	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.